New strategies for surgical management of ischemic cardiomyopathy

References

• Rosamond W, Flegal K, Friday G et al. Heart disease and stroke statistics – 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation115(5), e69–e171 (2007).
   PubMed Web of Science ®Google Scholar
• Jessup M, Brozena S. Heart Failure. N. Engl. J. Med.348 2007 (2003).
   Web of Science ®Google Scholar
• Felker GM, Shaw LK, O’Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J. Am. Coll. Cardiol.39, 210–218 (2002).
   PubMed Web of Science ®Google Scholar
• Mackay J, Mensah GA. The at last of heart disease and stroke In: World Health Organization. First Edition. Geneva, Switzerland, 1–112 (2004).
   Google Scholar
• Yancy CW. Comprehensive treatment of heart failure: state of the art medical therapy. Rev. Cardiovasc. Med.6(Suppl. 2), 43 (2005).
   Google Scholar
• Levy D, Kenchaiah S, Larson MG et al. Long term trends in the incidence of and survival with heart failure. N. Engl. J. Med.347, 1397 (2002).
   PubMed Web of Science ®Google Scholar
• Ahmed A, Aronow WS, Fleg JL. Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. Am. Heart J.151, 444–450 (2006).
   PubMed Web of Science ®Google Scholar
• Singh RR, Lisle RC, Kron IL. Surgical treatment of the failing heart. Minerva Cardioangiol.53, 287–297 (2005).
   PubMedGoogle Scholar
• Wellnhofer E, Olariu A, Klein C. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation109(18), 2172–2174 (2004).
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Smego D, Michler RE. Surgical aspects of congestive heart failure. Heart Fail. Rev.11(2), 171–192 (2006).
   PubMed Web of Science ®Google Scholar
• Taylor DO, Edwards LB, Boucek MM et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report – 2007. J. Heart Lung Transplant.26(8), 769–781 (2007).
   PubMed Web of Science ®Google Scholar
• Aziz T, Burgess M, Rahman AN et al. Cardiac transplantation for cardiomyopathy and ischemic heart disease, differences in outcome up to 10 years. J. Heart Lung Transplant.20(5), 525–533 (2001).
   PubMed Web of Science ®Google Scholar
• Phillips HR, O’Connor CM. Revasc for heart failure. Am. Heart J.153. 65–73 (2007).
   PubMedGoogle Scholar
• Chareonthaitawee P, Gersh BP, Araoz PA et al. Revascularization in severe left ventricular dysfunction: the role of viability testing. J. Am. Coll. Cardiol.46(4), 567–74 (2005).
   PubMed Web of Science ®Google Scholar
• Bax JJ, Visser FC, Poldermans D et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation.104(12 Suppl. 1), I314–I318 (2001).
   PubMed Web of Science ®Google Scholar
• Carluccio E, Biagioloi P, Alunni G et al. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. J. Am. Coll. Cardiol.47(5), 969–977 (2006).
   PubMed Web of Science ®Google Scholar
• Allman KC, Shaw LJ, Hachamovitch R et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J. Am. Coll. Cardiol.39(7), 1151–1158 (2002).
   PubMed Web of Science ®Google Scholar
• Bourque JM, Velazquez EJ, Borges-Neto S et al. Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis. Am. Heart J.146, 621–627 (2003).
   PubMed Web of Science ®Google Scholar
• Hunt SA, Abrahan WT, Chin H et al. 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J. Am. Coll. Cardiol.46(6), e1–e82 (2005).
   PubMed Web of Science ®Google Scholar
• Eagle KA, Guyton RA, Davidoff R et al. ACC/ AHA guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American heart task force (2004).
   Google Scholar
• Tarakji KG, Brunken R, McCarthy PM et al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation113, 230–237 (2006).
   PubMed Web of Science ®Google Scholar
• Doenst T, Velazquez EJ, Beyersdorf F et al. To STICH or not to STICH: we know the answer, but do we understand the question? J. Thorac. Cardiovasc. Surg.129(2), 246–249 (2005).
   PubMed Web of Science ®Google Scholar
• Cleland JG, Freemantle N, Ball SG et al. Coronary stenting in patients with depressed left ventricular function: acute and long-term results in a selected population. Catheter Cardiovasc. Interv.59, 429–433 (2003).
   PubMed Web of Science ®Google Scholar
• Beanlands R, Nichol G, Ruddy TD et al. Evaluation of outcome and cost effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rational, design, and methods. Control Clin. Trials24, 776–794 (2003).
   PubMedGoogle Scholar
• Baldasseroni S, Opasich C, Gorini M et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am. Heart J.143, 398–405 (2002).
   PubMed Web of Science ®Google Scholar
• Patel JB, Borgeson DD, Barnes ME et al. Mitral regurgitation in patients with advanced systolic heart failure. J. Card. Fail.10(4), 285–291 (2004).
   PubMed Web of Science ®Google Scholar
• Sarris GE, Cahill PD, Hansen DE et al. Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular-ventricular interaction. J. Thorac. Cardiovasc. Surg.95(6), 969–979 (1988).
   PubMed Web of Science ®Google Scholar
• Borger MA, Alam A, Murphy PM et al. Chronic ischemic mitral regurgitation: repair, replace or rethink? Ann. Thorac. Surg.81(3), 1153–1161 (2006).
   PubMed Web of Science ®Google Scholar
• Zeltsman D, Acker MA. Surgical management of heart failure. an overview. Annu. Rev. Med.53, 383–391 (2002).
   PubMed Web of Science ®Google Scholar
• Badhwar V, Bolling SF. Mitral valve surgery in the patient with left ventricular dysfunction. Semin. Thorac. Cardiovasc. Surg.14, 133–136 (2002).
   PubMedGoogle Scholar
• Gangemi JJ, Tribble CG, Ross SD et al. Does the additive risk of mitral valve repair in patients with ischemic cardiomyopathy prohibit surgical intervention? Ann. Surg.231(5), 710–714 (2000).
   PubMed Web of Science ®Google Scholar
• Di Donato M, Sabatier M, Dor V et al. Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery. J. Thorac. Cardiovasc. Surg.121(1), 91–96 (2001).
   PubMed Web of Science ®Google Scholar
• Athanasuleas CL, Buckberg GD, Stanley AW et al. Ventricular restoration in the treatment of congestive heart failure due to post-infraction ventricular dilation. J. Am. Coll. Cardiol.44(7), 1439–1445 (2004).
   PubMed Web of Science ®Google Scholar
• Menicanti L, Castelvecchio S, Ranucci M et al. Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular restoration. J. Thorac. Cardiovasc. Surg.134(2), 433–441 (2007).
   PubMed Web of Science ®Google Scholar
• Kaza AK, Patel MR, Fiser SM et al. Ventricular reconstruction results in improved left ventricular function and amelioration of mitral insufficiency. Ann. Surg.235(6), 828–832 (2002).
   PubMed Web of Science ®Google Scholar
• Adams JD, Fedoruk LM, Tache-Leon CA, et al. Does preoperative ejection fraction predict operative mortality with left ventricular restoration? Ann. Thorac. Surg.82(5), 1715–1719 (2006).
   PubMed Web of Science ®Google Scholar
• Fedoruk LM, Tribble CG, Kern JA et al. Predicting Operative Mortality After surgery for Ischemic Cardiomyopathy. Ann. Thorac. Surg.83, 2029–2035 (2007).
   PubMed Web of Science ®Google Scholar
• Cope JT, Kaza AK, Reade CC et al. A cost comparison of heart transplantation versus alternative operations for cardiomyopathy. Ann. Thorac. Surg.72(4), 1298–305 (2001).
   PubMed Web of Science ®Google Scholar
• Left ventricular aneurysm. In: Kirklin/ Barratt-Boyes Cardiac Surgery. Third Edition. Kouchoukos NT, Blackstone EH, Doty DB, Hanley FL, Karp RB (Eds). Elsevier Publishers, PA, USA 437–455 (2003).
   Google Scholar
• Parolari A , Naliato M, Loardi C et al. Surgery of left ventricular aneurysm: a meta-analysis of early outcomes following different reconstruction techniques. Ann. Thorac. Surg.83(6), 2009–2016 (2007).
   PubMed Web of Science ®Google Scholar
• Abraham WT, Fisher WG, Smith AL et al. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure: N. Engl. J. Med.346(24), 1845–1853 (2002).
   PubMed Web of Science ®Google Scholar
• Young JB, Abraham WT, Smith AL et al. Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA289(20), 2685–2694 (2003).
   PubMed Web of Science ®Google Scholar
• St John Sutton MG, Plappert T, Abraham WT et al. Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation107(15), 1985–1990 (2003).
   PubMed Web of Science ®Google Scholar
• Morgan JA, John R, Lee BJ et al. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann. Thorac. Surg.77(3), 859–863 (2004).
   PubMed Web of Science ®Google Scholar
• Rogers JG, Butler J, Lansman SL, Pierson et al. INTrEPID Investigators. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J. Am. Coll. Cardiol.50(8), 741–747 (2007).
   PubMed Web of Science ®Google Scholar
• Miller LW, Pagani FD, Russell SD et al. HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N. Engl. J. Med.357(9), 885–896 (2007).
   PubMed Web of Science ®Google Scholar
• Frazier OH, Gregoric ID, Cohn WE. Initial experience with non-thoracic, extraperitoneal, off-pump insertion of the Jarvik 2000 Heart in patients with previous median sternotomy. J. Heart Lung Transplant.25(5), 499–503 (2006).
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Zucker M, Arroyo L et al. Safety and feasibility trial of the MicroMed DeBakey ventricular assist device as a bridge to transplantation. J. Am. Coll. Cardiol.45(6), 962–963 (2005).
   PubMed Web of Science ®Google Scholar
• Esmore D, Spratt P, Larbalestier R et al. VentrAssist left ventricular assist device: clinical trial results and Clinical Development Plan update. Eur. J. Cardiothorac. Surg.32(5), 735–744 (2007).
   PubMed Web of Science ®Google Scholar
• Shuhaiber JH, Jenkins D, Berman M et al. The Papworth experience with the Levitronix CentriMag ventricular assist device. J. Heart Lung Transplant.27(2), 158–164 (2008).
   PubMed Web of Science ®Google Scholar
• Thiele H, Sick P, Boudriot E et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur. Heart J.26(13), 1276–1283 (2005).
   PubMed Web of Science ®Google Scholar
• Konstam MA, Czerska B, Böhm M et al. Continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure. Circulation112(20), 3107–3114 (2005).
   PubMed Web of Science ®Google Scholar
• Siegenthaler MP, Brehm K, Strecker T et al. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure. A three-center experience. J. Thorac. Cardiovasc. Surg.127(3), 812–822 (2004).
   PubMed Web of Science ®Google Scholar
• Copeland JG, Smith RG, Arabia FA et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N. Engl. J. Med.351(9), 859–867 (2004).
   PubMed Web of Science ®Google Scholar
• Dowling RD, Gray LA Jr, Etoch SW et al. Initial experience with the AbioCor implantable replacement heart system. J. Thorac. Cardiovasc. Surg.127(1), 131–141 (2004).
   PubMed Web of Science ®Google Scholar
• Patel SM, Throckmorton AL, Untaroiu A et al. The status of failure and reliability testing of artificial blood pumps. ASAIO J.51(4), 440–451 (2005).
   PubMed Web of Science ®Google Scholar
• Sabbah HN. Global left ventricular remodeling with the Acorn Cardiac Support Device: hemodynamic and angiographic findings in dogs with heart failure. Heart Fail. Rev.10(2), 109–115 (2005).
   PubMed Web of Science ®Google Scholar
• Mann DL, Acker MA, Jessup M et al. Acorn Trial Principal Investigators and Study Coordinators. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Ann. Thorac. Surg.84(4), 1226–1235 (2007).
   PubMed Web of Science ®Google Scholar
• Acker MA, Bolling S, Shemin R et al. Acorn Trial Principal Investigators and Study Coordinators. Mitral valve surgery in heart failure. Insights from the Acorn Clinical Trial. J. Thorac. Cardiovasc. Surg.132(3), 568–577 (2006).
   PubMed Web of Science ®Google Scholar
• Starling RC, Jessup M, Oh JK et al. Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year follow-up results from the Acorn clinical trial. Ann. Thorac. Surg.84(4), 1236–1242 (2007).
   PubMed Web of Science ®Google Scholar
• Fukamachi K, McCarthy PM. Initial safety and feasibility clinical trial of the myosplint device. J. Card. Surg.20(6), S43–S47 (2005).
   Web of Science ®Google Scholar
• Grossi EA, Saunders PC, Woo YJ et al. Intraoperative effects of the coapsys annuloplasty system in a randomized evaluation (RESTOR-MV) of functional ischemic mitral regurgitation. Ann. Thorac. Surg.80(5), 1706–1711 (2005).
   PubMed Web of Science ®Google Scholar
• Grossi EA, Woo YJ, Schwartz CF et al. Comparison of Coapsys annuloplasty and internal reduction mitral annuloplasty in the randomized treatment of functional ischemic mitral regurgitation: impact on the left ventricle. J. Thorac. Cardiovasc. Surg.131(5), 1095–1098 (2006).
   PubMed Web of Science ®Google Scholar
• Dib N, Michler RE, Pagani FD et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation112(12), 1748–1755 (2005).
   PubMed Web of Science ®Google Scholar